• Research Technician II-III

    Job ID
    Regular Full-Time
    Fred Hutchinson Cancer Research Center
    Laboratory Research Sciences
  • Overview

    Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network. Careers Start Here.



    This senior level technician will work independently under the direction of the principal investigator and scientific staff to design experiments; conduct literature reviews to assist in determining most suitable methods to be used in research and examine proposals to determine projects and methodologies best suited to research objectives and the overall goals of the laboratory. The incumbent will summarize and write for publication or presentation the results of research projects.


    The research technician will be involved in all aspects of murine preclinical studies in the Hingorani Laboratory, including but not limited to breeding, genotyping, ultrasound and other imaging techniques, and performing necropsies to obtain tissues for histology and cell lines. The technician may be involved in derivation, maintenance and study of primary cell lines; isolation of DNA, RNA, and proteins; as well as other techniques such as FACS sorting and expanding cells in vitro, analyzing cell phenotype and function using techniques including flow cytometry, proliferation assays, cytotoxicity assays, PCR, RT-PCR, sequencing, and ELISpot. Molecular techniques used in the lab include cloning, transfection/transduction of cell lines, gene targeting and northern and Southern blotting. Biochemical and cellular techniques include SDS-PAGE, western blotting, immunofluorescence, and immunohistochemistry. The technician will also assist with the management and organization of a fast-paced lab, and perform other duties as assigned by supervisor.


    • A Bachelor's degree in a biological field and at least 5 years of laboratory research experience including murine husbandry, cell tissue culture and molecular biology techniques are required
    • Master's degree in a biological field and at least 2 years of experience in the techniques listed above are highly desired
    • Computer skills: Microsoft Excel, Prism (Graphpad), FlowJo, and statistical programs for data analysis
    • Excellent organizational and interpersonal skills are required
    • Strong troubleshooting skills and the ability to multi-task with precise attention to detail is especially critical
    • Experience with genetically engineered murine models of pancreas cancer or other solid tumors is desired

    Our Commitment to Diversity

    We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We are proud to be an Equal Opportunity and VEVRAA Employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at escmail@fredhutch.org or by calling 206-667-4700.


    Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
    Share on your newsfeed